Skip to search.
 FTSE 100 Down 0.96%

AstraZeneca PLC (AZN)

-NYSE
28.10 5 May 21:02
|Pre-Market : 27.77 Down 0.32 (1.16%) 13:58 - Nasdaq Real Time Price
Prev Close:28.10
Open:N/A
Bid:27.76 x 1200
Ask:27.80 x 600
1y Target Est:35.41
Beta:0.57614
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:27.68 - 35.34
Volume:2,900
Avg Vol (3m):4,426,110
Market Cap:71.04b
P/E (ttm):25.20
EPS (ttm):1.12
Div & Yield:1.90 (6.57%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AZN 0.00%71.04b
GSK102.66b
PFE207.86b
MRK149.81b

Key Statistics

Forward P/E (1 yr):14.87
P/S (ttm):2.88
Ex-Dividend Date:17-Feb-16

Analysts

Annual EPS Est (Dec-16) :2.00
Quarterly EPS Est (Jun-16) :0.69
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-14.46

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of respiratory, inflammation, autoimmune, cardiovascular, metabolic, oncology, infection, neuroscience, and gastrointestinal d... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback